>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • SHEL -2.9% (provides Q2 production update; sees Q2 upstream production of 1,660 - 1,760 kboe/d; provides adjusted EBITDA guidance metrics).
Other news:
  • SOL -1% ( announces north america management change and preliminary Q2 2025 operating results ).
  • NRIX -1.6% (announces that the European Medicines Agency has granted Orphan Drug Designation to bexobrutideg for the treatment of lymphoplasmacytic lymphoma).
  • MAG -2% (reminds shareholders to vote "for" the arrangement with Pan American Silver (PAAS)).
  • UMC -2.3% (reports June 2025 sales +7.3% yr/yr to $18.8 bln).
  • FFAI -2.6% (Founder and Co-CEO, YT Jia, shares weekly investor update).
  • DEFT -3.8% (provides monthly AUM update).
  • TSLA -6.5% ( CEO Elon Musk creates "America Party", TSLA seeing increased competition in China, according to WSJ according to WSJ ).
  • BULL -9.3% ( announces $1 billion standby equity agreement; co intends on opportunistically using capital for key growth initiatives ).
  • NWTN -9.4% (announces Mr. Adrian Wong as Chief Financial Officer and Mr. John Xie as Chief Operating Officer; Both appointments effective July 3, 2025 ).
  • QSI -9.8% (announces pricing of $50 million registered direct offering of common stock ).
  • JSPR -73.4% (Reports Clinical Data Update from Briquilimab Studies in Chronic Spontaneous Urticaria ).

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • MOH +2.3% ( sees Q2 EPS below consensus; lowers FY25 guidance).
M&A news:
  • WNS +14.1% (Capgemini to acquire WNS for $76.50/share).
Other news:
  • APGE +18.7% (announces positive 16-week data from phase 2 APEX clinical trial of APG777, its potentially best-in-class Anti-IL-13 antibody, in moderate-to-severe atopic dermatitis ).
  • COGT +18.7% (announces "positive" top-line results from the registration-directed Part 2 of the SUMMIT clinical trial of bezuclastinib in patients with non-advanced systemic mastocytosis demonstrating clinically meaningful and highly statistically significant improvements across the primary and all key secondary endpoints, including patient-reported symptoms and objective measures of mast cell burden).
  • KALV +12.9% (announces FDA approval of EKTERLY, first and only oral on-demand treatment for hereditary angioedema).
  • SAND +9.6% (enters into definitive agreement with Royal Gold Inc. (RGLD) in which Royal Gold will acquire SAND in an all-share transaction with an implied value of approximately $3.5 bln ).
  • IREN +4.5% (publishes its monthly update for June 2025).
  • LXEO +4.5% (announces that the U.S. Food and Drug administration has granted Breakthrough Therapy designation to LX2006 based on clinical evidence generated on both cardiac and neurologic measures of Friedreich ataxia)
  • RKLB +3.9% (Barron's out positive on RKLB).
  • AEMD +3.2% ( Hemopurifier to Enhance Anti-PD1 Therapy; Assuming Coverage With Neutral Rating and $1.50 PT -- H.C. Wainwright).
  • LGIH +2.8% (announced it closed 457 homes in June 2025 and closed 1,323 homes in the second quarter of 2025).
  • DNLI +2.1% (FDA accepts BLA for review seeking accelerated approval for tividenofusp alfa for Hunter syndrome ).
  • AZN +1% ( Imfinzi approved in the EU as first and only perioperative immunotherapy for muscle-invasive bladder cancer).
  • OGN +1% (announces that VTAMA cream, 1%, was granted a strong recommendation by the American Academy of Dermatology in their 2025 focused guideline update for the management of adults with moderate to severe atopic dermatitis).

WSJ : Saudi Fund Invests Hundreds of Millions in Proposed NYC Skyscraper

Saudi Fund Invests Hundreds of Millions in Proposed NYC Skyscraper
The Kingdom’s Public Investment Fund is teaming with New York developer Related Cos.

  • Saudi Arabia’s Public Investment Fund is taking a two-thirds stake in the site of a planned Manhattan skyscraper project with Related Cos.
  • The project, potentially an office building, reflects foreign investors returning to New York’s recovering real-estate market.
  • PIF’s investment highlights its growing global property portfolio beyond Saudi megaprojects.

Saudi Arabia’s government fund is taking a two-thirds stake in a site for a planned Manhattan skyscraper, the latest sign that foreign investors are flocking back to New York’s rapidly recovering real-estate market.

The Kingdom’s Public Investment Fund is teaming with Related Cos., which has said it is planning to build a 1,200 foot tower on the site. The New York developer and the Saudis own this site one block from Central Park, which was purchased last year for more than $600 million.

Related initially planned a mixed-use project there with residential, retail and a hotel. But more recently the firm said it has been considering an office building instead to take advantage of the strong demand among businesses for top-quality space in the city.

The overall cost for the site and development is expected to be more than $1 billion, according to people familiar with the matter. The Saudi fund’s final contribution is still being determined, but PIF has already invested about $200 million, these people said.

Foreign investors this year have been returning to New York City’s commercial-property market, which is the largest, most liquid and one of the top performers in the U.S.

U.S. property developments and investments slowed considerably early on during the pandemic. They were hit again after interest rates soared in 2022, pushing down values. Foreign investor interest evaporated.

But lately investment in New York has been recovering as more workers return to the office, providing a new lift for neighboring businesses. Manhattan’s office leasing during the first half of the year surpassed the same period in some years before Covid-19’s outbreak, according to data firm CoStar Group.

New York City apartment rents are at all-time highs—boosting the mayoral candidacy of democratic socialist Zohran Mamdani, who recently won the Democratic primary while pledging a rent freeze. The city’s visitor numbers are just below record highs.

Eastdil Secured has seen the increase in foreign activity first hand. The real-estate brokerage and investment bank has $12 billion worth of New York real-estate deals completed or under way in 2025, according to Chief Executive Roy March.

“Virtually every one of them has some level of foreign capital involved,” he said.

Foreign investors purchased over $2.1 billion of Manhattan commercial property in the first quarter of 2025 and the last quarter of 2024 combined, according to data firm MSCI. That total was five times as much as the same six-month period two years earlier.

The Saudi Public Investment Fund has assets of about $1 trillion, making it one of the world’s largest investors. It is one of the major overseas funds returning to New York.

The fund has a close relationship with Related, best known for its sprawling Hudson Yards development on Manhattan’s west side. In 2020, the Saudi fund made a debt investment in Related that is convertible into a 15% equity stake. Since then the two have consulted closely on numerous real-estate projects.

Saudi’s Public Investment Fund has historically been a relatively small player in real estate outside of Saudi Arabia—instead directing its property-focused dollars toward domestic megaprojects meant to transform the country.

But in the past few years, it has planted its flag on a number of high-profile global properties and brands. Last year it took a 40% stake in Selfridges, a high-end U.K. department-store group that boasts a grand flagship by London’s Hyde Park.

In 2022, it joined with other funds to put $900 million into the ultraluxury hotelier Aman, and in 2023 bought a 49% stake in the upmarket hotel chain Rocco Forte.

>>> Congress passes and President Trump signs “One Big Beautiful Bill.” The bill

Congress passes and President Trump signs “One Big Beautiful Bill.” The bill includes extension of 2017 tax cuts, spending cuts (Medicaid and green energy spending), deregulation, energy reform, immigration reform, and a debt ceiling increase of $5 trillion (625.34)
  • The bill extends 2017 tax cuts for all income levels with an increased standard deduction. Tax cuts will be made permanent.
  • The bill eliminates taxes on tips and overtime through 2028 with some income limits.
  • The bill increases deductions for seniors on Social Security by $4000.
  • The bill makes permanent write-offs for business interest expenses and R&D.
  • The bill provides $170 billion for border security, construction of a border wall, and deportations.
  • The bill requires most solar and wind projects to be placed in service by 2027 to qualify for tax credits, with some carveouts for projects that get started by July of 2026 (the excise tax on solar & wind projects was removed from the bill).
  • Nuclear power credits will last until 2036. Hydrogen tax credits will be phased out in 2028.
  • EV tax credits will end in September of 2025.
  • The bill starts Medicaid work requirements beginning in December of 2026. The Medicaid provider tax will drop to 3.5% by 2028.
  • The bill creates a $50 billion fund for rural hospitals.
  • The bill makes auto loan interest tax deductible.
  • The bill will limit gambling loss write-offs for recreational gamblers to 90% of winnings for that tax year (previous deduction was allowed at 100% of winnings).
  • The bill raises the debt ceiling by $5 trillion.
  • The bill raises the state and local tax deduction to $40,000 for people making $500K or less. SALT cap will go back to $10K after 5 years.
  • The bill makes changes to the IRS free tax filing program, pending review by a task force.
  • The bill includes tax on college endowments and private foundations.
  • The bill requires states to share the cost of some SNAP benefits.
  • The bill limits how much students can borrow from the government for college.
  • The bill includes reforms for how pharmacy benefit managers do business with the government.
  • The bill creates a new savings account for children, and $1000 of funding will be provided.
  • The bill provides new tax credits for nuclear energy.
  • The bill will provide billions for the construction of the "Golden Dome" missile defense shield.
  • The bill raises the child tax credit to $2200 from $2000.
  • The bill provides additional money for air traffic control and some other defense programs.
  • The bill provides additional tax credits for semiconductor companies that build capacity in the U.S.

Full Bill Text

Deficit Impact:
The CBO said that the Senate bill will add $3.3 trillion to deficits over the next 10 years. The CBO "estimates that enacting the substitute amendment would increase by 11.8 million the number of people without health insurance in 2034. That amount includes an estimated 1.4 million people without verified citizenship, nationality, or satisfactory immigration status who would no longer be covered in state-only funded programs in 2034."
Related stocks: TAN, FSLR, SPWR, CSIQ, SUN, NEE, GEV, CWEN, CHPT, EVGO, BLNK, TSLA, RIVN, F, GM, STLA, HMC, TM, FSR, LCID, CXW, GEO, UNH, HUM, CNC, CVS, ALHC, MOH, CI, ELV, THC, UHS, CYH, HCA, HRB, INTU, SAH, CVNA, AN, PAG, GPI, NLR, CCJ, URA, CAE, GD, LMT, NOC, LHX, LIN, APD, PLUG, BE, TOL, LEN, DHI, NVR, CZR, MGM, WYNN, LVS, DKNG, FLUT, PENN, DG, DLTR, FIVE, WMT, SOFI, SLM, SMH, AMD, INTC, AVGO, TSM, AVGO

>>> Europe : Brokers Upgrades & Downgrades - 7th of July 2025 V3(++)

>>> Up
* Allianz PT Raised to 431 euros from 419 euros at Berenberg
* Berkeley Raised to Buy at Peel Hunt
* Bilfinger PT Raised to 100 euros at Bankhaus Metzler
* Constellation Brands Raised to Buy at Jefferies; PT $205 (++)
* Generali Raised to Overweight at JPMorgan; PT 37 euros
* Nordea Bank Raised to Hold at Kepler Cheuvreux (+)
* Norwegian Air Raised to Hold at ABG; PT 14 kroner
* Nvidia PT Raised to $190 from $180 at Citi (+)
* ProSieben Raised to Overweight at JPMorgan; PT 11 euros
* Schindler PT Raised to 330 Swiss francs at Bank Vontobel (+)
* T-Mobile Raised to Neutral at Rothschild & Co Redburn

>>> Down
* Aixtron Cut to Hold at Kepler Cheuvreux; PT 17 euros (++)
* Applied Materials Cut to Neutral at Rothschild & Co Redburn (+)
* Atrium Ljungberg Cut to Hold at Kepler Cheuvreux (+)
* Currys Cut to Sector Perform at RBC
* Duell Cut to Reduce at Inderes; PT 4.80 euros
* Embla Medical HF Cut to Hold at ABG; PT 35 kroner
* Inter Cars Cut to Neutral at Citi; PT 645 zloty
* Kion Cut to Hold at mwb research AG; PT 46 euros (++)
* Merck KGaA Cut to Sell at Stifel; PT 100 euros
* Netflix Cut to Neutral at Seaport Global Securities
* Netflix Cut to Neutral at President Capital Management (+)
* Pandora Cut to Hold at HSBC; PT 1,250 kroner
* Pop. Sondrio Cut to Reduce at Equita; PT 9.90 euros (+)
* Poste Italiane Cut to Neutral at JPMorgan; PT 20 euros
* Stellantis Cut to Neutral at BofA (+)
* Tesla Cut to Market Perform at William Blair (++)
* Wacker Chemie Cut to Hold at DZ Bank; PT 70 euros (++)

>>> Initiation
* Angle Rated New Buy at Singer Capital Markets; PT 17 pence (++)
* Allfunds Rated New Buy at Deutsche Bank; PT 8.50 euros (+)
* Aurubis Rated New Hold at Baptista Research; PT 99.10 euros
* BCP Rated New Neutral at Citi; PT 70 euro cents
* Boku Rated New Buy at Canaccord; PT 271 pence (+)
* Cheniere Energy Rated New Buy at Mirae Asset Securities; PT $290
* Dassault Systemes ADRs Rated New Underperform at BNPP Exane (++)
* Faron Pharma Rated New Buy at Bryan Garnier; PT 371.31 pence (+)
* Inmobiliaria Colonial Resumed Buy at Citi
* Poste Italiane Rated New Outperform at Baptista Research
* Prysmian Rated New Hold at Baptista Research; PT 68.30 euros
* Remy Cointreau Reinstated Neutral at BNPP Exane; PT 42 euros (++)
* Rockwell Automation Rated New Outperform at CICC; PT $381
* Rosebank Rated New Buy at Stifel; PT 420 pence (+)
* Skinbiotherapeutics Rated New Buy at Singer Capital Markets (++)
* Snam Rated New Hold at Baptista Research; PT 5.50 euros
* Tenaris Rated New Hold at Baptista Research; PT 18.20 euros
* Voyager Technologies Rated New Buy at Jefferies; PT $50
* Wacker Chemie Rated New Buy at Baptista Research; PT 91.20 euros

>>> Call
* Penmaker BIC’s Shares Fall After UBS Analyst Cuts Estimates, PT (++)
* Currys Downgraded at RBC, Valuation Fair and Macro Outlook Mixed
* Deutsche Bank Strategists Say Equity Exposure Nearing Neutral (+)
* Generali Raised, While Poste Italiane Downgraded at JPMorgan
* JPMorgan’s Matejka Sees European Stocks Consolidating Further (+)
* Merck KGaA Double Downgraded at Stifel on Patent Expiry Risk (+)
* MGM Rated Sell at Goldman on Vegas Pressures; Caesars Rated Buy (++)
* Pandora Drops as HSBC Downgrades; Price Target and Estimates Cut (++)
* Shell Slides After RBC Says Weak Update Breaks Positive Streak (+)
* Stellantis Cut to Neutral at BofA on Fears of ‘Very Weak’ 1H (+)
* Vidrala Maintained Outperform at Grupo Santander (++)
* Weir Seems Primed for a Re-Rating, Citi Upgrades Shares to Buy

>>> Europe : Brokers Upgrades & Downgrades - 7th of July 2025 V2(+)

>>> Up
* Allianz PT Raised to 431 euros from 419 euros at Berenberg
* Berkeley Raised to Buy at Peel Hunt
* Bilfinger PT Raised to 100 euros at Bankhaus Metzler
* Generali Raised to Overweight at JPMorgan; PT 37 euros
* Nordea Bank Raised to Hold at Kepler Cheuvreux (+)
* Norwegian Air Raised to Hold at ABG; PT 14 kroner
* Nvidia PT Raised to $190 from $180 at Citi (+)
* ProSieben Raised to Overweight at JPMorgan; PT 11 euros
* Schindler PT Raised to 330 Swiss francs at Bank Vontobel (+)
* T-Mobile Raised to Neutral at Rothschild & Co Redburn

>>> Down
* Applied Materials Cut to Neutral at Rothschild & Co Redburn (+)
* Atrium Ljungberg Cut to Hold at Kepler Cheuvreux (+)
* Currys Cut to Sector Perform at RBC
* Duell Cut to Reduce at Inderes; PT 4.80 euros
* Embla Medical HF Cut to Hold at ABG; PT 35 kroner
* Inter Cars Cut to Neutral at Citi; PT 645 zloty
* Merck KGaA Cut to Sell at Stifel; PT 100 euros
* Netflix Cut to Neutral at Seaport Global Securities
* Netflix Cut to Neutral at President Capital Management (+)
* Pandora Cut to Hold at HSBC; PT 1,250 kroner
* Pop. Sondrio Cut to Reduce at Equita; PT 9.90 euros (+)
* Poste Italiane Cut to Neutral at JPMorgan; PT 20 euros
* Stellantis Cut to Neutral at BofA (+)
* Vidrala Cut to Neutral at Grupo Santander; PT 109.11 euros (+)

>>> Initiation
* Allfunds Rated New Buy at Deutsche Bank; PT 8.50 euros (+)
* Aurubis Rated New Hold at Baptista Research; PT 99.10 euros
* BCP Rated New Neutral at Citi; PT 70 euro cents
* Boku Rated New Buy at Canaccord; PT 271 pence (+)
* Cheniere Energy Rated New Buy at Mirae Asset Securities; PT $290
* Faron Pharma Rated New Buy at Bryan Garnier; PT 371.31 pence (+)
* Inmobiliaria Colonial Resumed Buy at Citi
* Poste Italiane Rated New Outperform at Baptista Research
* Prysmian Rated New Hold at Baptista Research; PT 68.30 euros
* Rockwell Automation Rated New Outperform at CICC; PT $381
* Rosebank Rated New Buy at Stifel; PT 420 pence (+)
* Snam Rated New Hold at Baptista Research; PT 5.50 euros
* Tenaris Rated New Hold at Baptista Research; PT 18.20 euros
* Voyager Technologies Rated New Buy at Jefferies; PT $50
* Wacker Chemie Rated New Buy at Baptista Research; PT 91.20 euros

>>> Call
* Currys Downgraded at RBC, Valuation Fair and Macro Outlook Mixed
* Deutsche Bank Strategists Say Equity Exposure Nearing Neutral (+)
* Generali Raised, While Poste Italiane Downgraded at JPMorgan
* JPMorgan’s Matejka Sees European Stocks Consolidating Further (+)
* Merck KGaA Double Downgraded at Stifel on Patent Expiry Risk (+)
* Shell Slides After RBC Says Weak Update Breaks Positive Streak (+)
* Stellantis Cut to Neutral at BofA on Fears of ‘Very Weak’ 1H (+)
* Weir Seems Primed for a Re-Rating, Citi Upgrades Shares to Buy

FT : EV battery maker’s profits more than double on back of Biden-era tax break

EV battery maker’s profits more than double on back of Biden-era tax break
LG Energy Solution estimates $360mn in operating income in boost from projected $1mn without credit

LG Energy Solution’s profits more than doubled unexpectedly in the second quarter, as the world’s third-largest electric vehicle battery producer benefited from Joe Biden’s tax credits that are set to be scaled back under his successor Donald Trump.

The South Korean supplier to General Motors and Tesla on Monday estimated its operating profit for April to June to be Won492bn ($360mn), up 152 per cent from year earlier. It was much higher than the Won294bn profit forecast by analysts in an LSEG estimate. Sales are estimated to have fallen 9.7 per cent to Won5.6tn.

Analysts said the company’s US plants produced more batteries than expected as carmakers appeared to frontload orders over fears of higher tariffs on cars. This raised profits for LGES, as it continued to reap benefits from a production tax credit for clean energy under Biden’s Inflation Reduction Act.

Excluding the so-called advanced manufacturing production credit, second-quarter operating profit would be just Won1.4bn, LGES estimated, with its operating profit margin at 0.03 per cent.

LGES, the world’s largest non-Chinese battery producer, was among the main beneficiaries of the Biden-era act, which sought to decrease US dependence on Chinese clean energy technology and offered tax breaks for EV purchases and EV technology production.

Some of those subsidies will be scaled back under Trump’s sweeping budget bill. A $7,500 tax credit for consumers who buy or lease EVs and a $4,000 credit for the purchase of a used EV will be eliminated. “The scrapped tax credits will probably hurt EV demand,” said Kim Chul-joong, an analyst at Mirae Asset Securities.

However, tax incentives for companies that produce and sell EV batteries in the US, such as LGES, will remain intact until 2032. The legislation also tightens restrictions on Chinese and China-invested companies’ access to federal tax credits.

“We are relieved that the AMPC will be maintained and the clause on foreign entities of concern has been strengthened, making it more difficult for Chinese companies to benefit from the tax scheme, which is good for us,” said a spokesperson for LGES.

Global EV battery usage excluding China rose by 26 per cent in the first five months of this year compared with 25 per cent during the same period last year, according to SNE Research.

Usage of LG batteries grew by 13 per cent in that time, while usage of batteries produced by Chinese giant and global market leader CATL grew by 36 per cent.

Monday’s upbeat profit estimate boosted the company’s shares 2.4 per cent to Won318,000, while the benchmark Kospi index was little changed.  

The company’s shares have fallen more than 8 per cent so far this year on a prolonged decline in EV demand. LGES is expected to release detailed quarterly results later this month.

TechCrunch : At least 36 new tech unicorns were minted in 2025 so far

At least 36 new tech unicorns were minted in 2025 so far

With AI igniting an investor frenzy, every month, more startups obtain unicorn status.

Using data from Crunchbase and PitchBook, TechCrunch tracked down the VC-backed startups that became unicorns so far this year. While most are AI-related, a surprising number are focused in other industries like satellite space companies like Loft Orbital and blockchain-based trading site Kalshi.

This list will be updated throughout the year, so check back and see the latest powerhouse startups who are now worth over $1 billion.

June
Linear — $1.25 billion: This software development product management tool last raised an $82 million Series C, valuing the company at $1.25 billion, according to Pitchbook. The company, founded in 2019, has raised more than $130 million in funding to date from investors including Accel and Sequoia Capital.

Gecko — $1.62 billion: This company makes data-gathering robotics that climb, crawl, swim, and fly. Founded in 2013, the company last raised a $121 million Series D, valuing the company at $1.6 billion, according to Pitchbook. The company has raised more than $340 million in funding to date from investors including Cox Enterprises and Drive Capital.

Meter — $1.38 billion: This company, which offers managed Internet infrastructure service to enterprises, last raised a $170 million Series C, valuing the company at $1.38 billion, according to Pitchbook. The company, founded in 2015, has raised more than $250 in funding to date, from investors including General Catalyst, Sequoia Capital, Sam Atlaman, and Lachy Groom.

Teamworks — This sports software company last raised a $247 million Series F, valuing the company at $1.25 billion, according to Pitchbook. The company, founded in 2006, has raised more than $400 million in funding to date from investors including Seaport Capital and General Catalyst.

Thinking Machines — This AI research company, founded just last year by OpenAI alumn Mira Murati, raised a $2 billion seed round, valuing the company at $10 billion, according to Pitchbook. The company’s investors include a16z and Nvidia.

Kalshi — $2 billion: The popular prediction markets company, founded in 2018, last raised an $185 million Series C, valuing the company at $2 billion, according to Pitchbook. The company has raised more than $290 million in funding to date, from investors including Sequoia and Global Founders Capital.

Decagon — This customer service AI agent company, founded in 2023, last raised a $131 million Series C, valuing the company at $1.5 billion, according to Pitchbook. The company has raised more than $231 million in funding to date, from investors including a16z and Accel.

May
Pathos — $1.6 billion: This drug development company, founded in 2020, last raised a $365 million Series D, valuing the company at $1.6 billion, according to Pitchbook. The company has raised more than $460 million to date from investors, including General Catalyst and Altimeter Capital Management.

Statsig — $1.1 billion: This product development platform, founded in 2021, last raised an $100 million Series C, valuing the company at $1.1 billion, according to Pitchbook. The company has raised around $153 million to date, from investors including Sequoia, Mardona, and ICONIQ Growth.

SpreeAI — $1.5 billion: This shopping tech company last raised an undisclosed round, according to Pitchbook, that valued the company at $1.5 billion. The company, founded in 2020, has raised more than $20 million to date from investors including The Davidson Group.

Function — $2.5 billion: This health tech company, founded in 2020, last raised a $200 million round, according to Pitchbook, valuing the company at $2.5 billion. The company has raised more than $250 million in funding to date, from investors including a16z.

Owner — $1 billion: This restaurant marketing software company, founded in 2018, last raised a $120 million Series C, valuing the company at $1 billion, per Pitchbook. The company has raised more than $180 million in funding to date, from investors including Headline, Redpoint Ventures, SaaStr Fund, and Meritech Capital.

Awardco — $1 billion: This employee engagement platform last raised a $165 million Series B, valuing the company at $1 billion, per Pitchbook. The company, founded in 2012, has raised more than $230 million in funding to date, from investors including General Catalyst.

April
Nourish — $1 billion: This dietitian tele-health company last raised a $70 million Series B, according to Pitchbook, valuing the company at $1 billion. The company, founded in 2020, has raised more than $100 million in funding to date from investors including Index Ventures and Thrive Capital.

Chapter — $1.38 billion: This Medicare guide health tech company, founded in 2013, last raised a $75 million Series D, valuing it at $1.38 billion, according to Pitchbook. The company has raised $186 million in funding to date, with investors including XYZ Venture Capital and Narya.

Threatlocker — $1.2 billion: This Orlando-based data protection company last raised a $60 million Series E, valuing the company at $1.2 billion, according to Pitchbook. The company, founded in 2017, has raised more than $200 million in funding to date, from investors including General Atlantic and StepStone Group.
Cyberhaven — $1 billion: This data detection company last raised a $100 million Series D in April, according to Pitchbook, valuing the company at $1 billion. The company, launched in 2015, has raised more than $200 million in funding to date, with investors including Khlosa Ventrues and Redpoint Ventures.

March
Fleetio — $1.5 billion: This Alabama-based startup creates software to help make fleet operations easier. It last raised a $454 million Series D at a $1.5 billion valuation, according to PitchBook. It was launched in 2012 and has raised $624 million in funding to date, with investors including Elephant and Growth Equity at Goldman Sachs Alternatives.

The Bot Company — $2 billion: This robotics platform last raised a $150 million early-stage round, valuing it at $2 billion, according to PitchBook. The company, which was founded in 2024, has raised $300 million to date in funding.

Celestial AI — $2.5 billion: The AI company raised a $250 million Series C led by Fidelity that valued the company at $2.5 billion, per Crunchbase. The company, based in California, was launched in 2020 and counts BlackRock and Engine Ventures as investors. It has raised more than $580 million in capital to date, per PitchBook.

Underdog Fantasy — $1.3 billion: The sports gaming company last raised a $70 million Series C valuing the company at $1.3 billion, according to Crunchbase. The company, founded in 2020, has raised more than $100 million in capital to date, per PitchBook. Investors include Spark Capital.

Build Ops — $1 billion: This software company last raised a $122.6 million Series C, valuing it at $1 billion. Build Ops, which was launched in 2018, has raised $273 million in total, according to PitchBook, with investors including Founders Fund and Fika Ventures.

Insilico Medicine — $1 billion: The drug research company raised a $110 million Series E valuing the company at $1 billion, per Crunchbase. It launched in 2014, has raised more than $500 million to date in capital, and counts Lilly Ventures and Value Partners Group as investors.

Olipop — $2 billion: This popular probiotic soda company last raised a $137.9 million Series C at a $1.96 billion valuation. It was founded in 2018 and has raised $243 million to date with investors including Scoop Ventures and J.P. Morgan Growth Equity Partners.

Peregrine — $2.5 billion: This data analysis and integration platform, launched in 2017, last raised a $190 million Series C with a valuation of $2.5 billion. It has raised more than $250 million in funding to date, according to PitchBook, with investors including Sequoia and Fifth Down Capital.

Assured — $1 billion: The AI company helps process claims and last raised a $23 million Series B, valuing the company at $1 billion. It was launched in 2019 and has raised a little more than $26 million to date, with investors including ICONIQ Capital and Kleiner Perkins.

February
Abridge — $2.8 billion: This medtech company, founded in 2018, last raised a $250 million Series D at a $2.75 billion valuation, per PitchBook. The company has raised more than $460 million to date in funding and counts Elad Gil and IVP as investors.

OpenEvidence — $1 billion: This medtech company, founded in 2017, last raised a $75 million Series A at a $1 billion valuation, per PitchBook. The company has raised $135 million to date in funding and counts Sequoia Capital as an investor.

Hightouch — $1.2 billion: The data platform, founded in 2018, last raised an $80 million Series C at a $1.2 billion valuation, per PitchBook. The company has raised $171 million to date in funding and counts Sapphire Ventures and Bain Capital Ventures as investors.

January
Kikoff — $1 billion: This personal finance platform last raised an undisclosed amount that valued it at $1 billion, according to PitchBook. The company, founded in 2019, has raised $42.5 million to date and counts Female Founders Fund, Lightspeed Venture Partners, and basketballer Steph Curry as investors.

Netradyne — $1.35 billion: Founded in 2015, this computer vision startup raised a $90 million Series D valuing it at $1.35 billion, according to Crunchbase. The round was led by Point72 Ventures.

Hippocratic AI — $1.6 billion: This startup, founded in 2023, creates healthcare models. It raised a $141 million Series B, valuing it at $1.64 billion, according to Crunchbase. The round was led by Kleiner Perkins.

Truveta — $1 billion: This genetic research company raised a $320 million round valuing it at $1 billion, according to Crunchbase. Founded in 2020, its investors include the CVCs from Microsoft and Regeneron Pharmaceuticals.

Clay — $1.25 billion: Founded in 2017, Clay is an AI sales platform. The company raised a $40 million Series B, valuing it at $1.25 billion, according to PitchBook. It has raised more than $100 million to date and counts Sequoia, First Round, Boldstar, and Box Group as investors.

Mercor — $2 billion: This contract recruiting startup raised a $100 million Series B valuing it at $2 billion. The company, founded in 2022, counts Felicis, Menlo Ventures, Jack Dorsey, Peter Thiel, and Anthology Fund as investors.

Loft Orbital — $1 billion: Founded in 2017, the satellite company raised a $170 million Series C valuing the company at $1 billion, according to Crunchbase. Investors in the round included Temasek and Tikehau Capital.

WSJ : The Shy Billionaire Who Built an Empire of Superteams

The Shy Billionaire Who Built an Empire of Superteams
With a $10 billion deal for the Los Angeles Lakers, Guggenheim CEO Mark Walter is adding another trophy asset to a portfolio that makes him one of the most influential individuals in sports

  • Mark Walter, Guggenheim Partners CEO, acquired the Los Angeles Lakers, adding to his sports portfolio.
  • Walter’s sports investments include the Los Angeles Dodgers, Chelsea FC, and Cadillac Formula 1, reflecting a strategy for long-term gain.
  • Known for his quiet demeanor, Walter focuses on winning and long-term strategy, letting others be the public face of his sports ventures.


Over the course of Mark Walter’s slow journey to build one of the most glittering portfolios in sports, doing a $10 billion deal to buy the Los Angeles Lakers turned out to be the easy part.

Every other major acquisition—including the Los Angeles Dodgers, Chelsea FC, and the Cadillac Formula One team—had turned into protracted affairs that required the involvement of bankruptcy courts, suspicious rivals, or the British government. But when news first emerged last month that Walter, the CEO of Guggenheim Partners, was taking over the Lakers, it was already a fait accompli.

The transaction not only made Walter the overnight owner of the world’s priciest team. It also turned the shy billionaire from Cedar Rapids, Iowa into one of the most influential people in sports.

“A few things I can tell you about Mark—he is driven by winning, excellence, and doing everything the right way,” tweeted Lakers legend Magic Johnson, who is also one of Walter’s business partners in the Dodgers. “AND he will put in the resources needed to win.”

At a time when the soaring price of buying a top-tier professional team has shrunk the pool of possible owners, the 65-year-old Walter is in elite company among investors whose sports portfolios span the richest leagues on several continents.

The club includes a handful of other billionaires expanding personal empires, such as Los Angeles Rams and Arsenal owner Stan Kroenke or John Henry and Tom Werner at Fenway Sports Group. But the very top of the pyramid is increasingly populated by private equity-led consortia and sovereign-wealth funds, who are prepared to plow billions into building superteams.

“I hate losing,” Walter said in a rare interview alongside Johnson a year ago at a Milken Institute conference. “I just can’t stand it.”

Not that Walter is terribly familiar with defeat. His personal wealth, widely estimated to be in the 10 figures, came from starting the bond manager and investment bank Guggenheim Partners 25 years ago with backing from a member of the Guggenheim family and a Texas conglomerate. He later branched into insurance and spotted a rare efficiency: Walter realized that years of steady premiums could be a good match for multigenerational investments in sports, fast food and technology.

Alongside Hollywood producer Thomas Tull and Abu Dhabi’s Mubadala investment fund, he has also used a company called TWG Global to put money into life insurance companies, western rodeos, a stake in online car dealer Carvana and an investment in Colossal Biosciences, which aims to bring back the woolly mammoth and the dodo.

But it was the 2012 purchase of the Dodgers, for an MLB-record $2.15 billion, that thrust Walter into the limelight beyond the world of finance. Though many critics had seen it as too expensive, Walter’s investing group registered an almost immediate paper gain by raising $3 billion in funding from the team’s broadcasting rights. The team is now worth around $7 billion, boasts the best player of his generation in Shohei Ohtani, and streams its games to a huge market Japan.

“The market drove the price,” Walter, who hadn’t attended a live major-league game until his 20s, said at the time. The investment was “a multigenerational thing my daughter’s granddaughters will own.”

That purchase set the tone for Walter’s investment in brands with broad appeal and multiple revenue sources. Beyond the usual array of sponsorships, merchandise and fan experiences, he has targeted long-term gain from projects such as developing a new London home for Chelsea and hundreds of acres of land around Dodgers Stadium.

The same philosophy guided his entry into one of the fastest-growing sports of the past five years, Formula One. TWG has partnered with General Motors to build Cadillac F1 from scratch and make it the 11th team on the grid from next year. The 10 other outfits took some convincing—after all, why should they carve out an extra slice of their pie? But a one-time fee of $450 million paid by Cadillac’s backers and divided equally among the teams helped soften the blow.

“We needed to be sure that it would have been the right decision for the sport without being too selfish,” F1 CEO Stefano Domenicali said.

Walter’s associates refer to him as a business genius, who demands results (with Midwestern manners), but strategizes in years and decades. Though he and his wife Kimbra are rarely seen at glitzy events, they have owned some of the finest homes in Chicago, Newport, R.I. and Los Angeles, including an $85 million mansion on Malibu’s Carbon Beach that burned to the ground in this year’s wildfires.

“I’m a fairly quiet and private person,” he told the Chicago Tribune in 2012. “So I haven’t sought publicity.”

That explains why Walter has usually let someone else be the face of his various sports properties. At the time of the Dodgers acquisition, the name in the headlines wasn’t the consortium’s largest investor, but rather its most recognizable, a charismatic superstar named Magic. At Chelsea, meanwhile, the club’s most visible presence is Walter’s co-owner Todd Boehly, who is routinely spotted at home games at Stamford Bridge—and is the one on the receiving end of supporters’ anger.

But wherever he invests his money, there is no question over who calls the shots for the long term. As Johnson put it in May 2024, “We just follow the leader.”